Global Infectious Disease Diagnostics Testing Market 2015-2019
About infectious disease diagnostic
Infectious diseases are disorders caused by micro-organisms such as viruses, bacteria, fungi, and parasites. These diseases can be transmitted from one individual to another through either direct contact or indirect contact. Anti-infective drugs are used to kill (cidal) or stop the growth (static) of infectious agents. Based on the target organism, anti-infective drugs can be categorized into antibacterial, antiviral, antifungal, and antiparasitic. Anti-infective drugs can act via host defense system or can directly target the causative agent. Infectious diseases such as bacterial infections, respiratory diseases, HPV, and HIV are gradually increasing worldwide. For instance, based on the study of WHO global health observatory (GHO) data, it is estimated that in 2013 34-38 million people suffered from HIV infection worldwide. Infectious diseases increasingly threaten public health and contribute significantly to the rising costs of health care. Infectious disease diagnostic tests help in detecting new pathogens and specific pathogens, monitoring response to therapy, assessing prognosis, and determining appropriate treatment.
Technavio's analysts forecast the global infectious disease diagnostic testing market to grow at a CAGR of 11.48% over the period 2014-2019.
Covered in this report
The report covers the present scenario and growth prospects of the global infectious disease diagnostic testing market for the period 2015-2019. To calculate the market size, the report considers revenue generated from the sales of following product categories:
Molecular diagnostic test
POC infectious disease diagnostics test
POC infectious disease diagnostics test is classified into the following based on application:
Technavio's report, Global Infectious Disease Diagnostic Testing Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers APAC, Europe, Latin America, MEA, and North America; it also covers the landscape of the global infectious disease diagnostic testing market and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market
Other prominent vendors
Becton, Dickinson and Company (BD)
Gold Standard Diagnostics
rtho Clinical Diagnostics
Siemens Healthcare Diagnostics
Thermo Fisher Scientific
Trinity BiotechKey market driver
Increase in prevalence of infectious diseases
For a full, detailed list, view our reportKey market challenge
Emerging infectious diseases
For a full, detailed list, view our reportKey market trend
Advances in technology
For a full, detailed list, view our reportKey questions answered in this report
What will the market size be in 2019 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?
Technavio Announces the Publication of its Research Report – Global Infectious Disease Diagnostic Testing Market 2015-2019
Technavio recognizes the following companies as the key players in the Global Infectious Disease Diagnostic Testing Market: Abbott Diagnostic, Alere, bioMérieux, Diasorin, and Roche Diagnostic.
Other Prominent Vendors in the market are: Beckman Coulter, Becton, Dickinson and Company (BD), Bio-Rad Laboratories, Cavidi, Cepheid, Corgenix, Diaxonhit, Eiken Chemical, EMD Millipore, Epitope Diagnostic, EUROIMMUN, Gold Standard Diagnostics, Hologic, Immunetics, InBios International, J.Mitra, Meridian Bioscience, OraSure Technologies, ORGENTEC Diagnostika, Ortho Clinical Diagnostics, QIAGEN, Quidel, Siemens Healthcare Diagnostics, TECHLAB, Thermo Fisher Scientific, and Trinity Biotech.
Commenting on the report, an analyst from Technavio’s team said: “Nano or microfluidic technologies are emerging as a powerful tool to detect, diagnose, and monitor infectious diseases. The miniaturized microfluidic platforms are used for small fluid volumes to provide diagnosis in a rapid and accurate manner.”
According to the report, many vendors are focusing on patient-centered models with new innovative POC diagnostic testing. In 2014, consumer-facing POC marketing expenditure by pharmaceutical and medical devices companies was estimated to be around $400 million.
Further, the report states that diagnostics manufacturers face a major challenge in developing integrated diagnostic tools.
Abbott Diagnostic, Alere, bioMérieux, Diasorin, Roche Diagnostic, Beckman Coulter, Becton, Dickinson and Company (BD), Bio-Rad Laboratories, Cavidi, Cepheid, Corgenix, Diaxonhit, Eiken Chemical, EMD Millipore, Epitope Diagnostic, EUROIMMUN, Gold Standard Diagnostics, Hologic, Immunetics, InBios International, J.Mitra, Meridian Bioscience, OraSure Technologies, ORGENTEC Diagnostika, Ortho Clinical Diagnostics, QIAGEN, Quidel, Siemens Healthcare Diagnostics, TECHLAB, Thermo Fisher Scientific, Trinity Biotech.